Surgical robots are proving their worth at Hadassah Hospital in Jerusalem, where Medtronic’s robotic guidance system removed a bullet lodged in a soldier’s sacrum in just 90 minutes, preventing paralysis and lead poisoning.

By Jewish Breaking News

Israel’s defensive war in Gaza has been devastating, with 818 soldiers dead, 12,000 in rehabilitation, 40% with limb trauma, and a third of troops battling psychological wounds.

But inside Israel’s hospitals, a quiet revolution in combat medicine is taking shape.

Designed for amputees haunted by phantom pain, Israeli startup 6Degrees has developed the MyMove system, now employed at Sheba Medical Center in Ramat Gan.

Patients wear lightweight bands and VR headsets, engaging with games where virtual versions of their lost limbs move naturally. Clinical trials show 88% of users report significant pain relief.

For IDF soldier Aaron Bours, who lost over three inches of bone in his right leg while attempting to rescue his commanding officer, MyMove has been a game-changer.

“I broke a sweat like I hadn’t done in many months. It’s fun, so the results are that much better,” Bours tells the New York Post. “We’re a survivalist nation. We have to be because otherwise we’d die.”

At Sheba’s 3D Center, surgeons used a precisely designed skull model to reconstruct IDF officer Omri Rosenblit’s facial structure after he was severely injured when a building collapsed on him in Khan Yunis.

The technology even helped restore his vision. In another remarkable case, a 3D-printed implant helped reconstruct a shattered IDF canine’s skull.

Surgical robots are proving their worth at Hadassah Hospital in Jerusalem, where Medtronic’s robotic guidance system removed a bullet lodged in a soldier’s sacrum in just 90 minutes, preventing paralysis and lead poisoning.

Meanwhile, Aidoc’s AI-powered medical imaging system is transforming emergency response, demonstrated dramatically when it helped save a 23-year-old Nova massacre survivor by mapping a bullet’s path through her brain in seconds.

The psychological toll of war has spurred equally innovative mental health solutions.

GenAI-powered platform LIV at Sheba helps overwhelmed psychiatrists by conducting initial patient interviews and gathering clinical data.

By the time patients meet with a psychiatrist, LIV’s detailed summaries allow doctors to focus on decision-making rather than lengthy intake sessions.

At Tel Aviv University, researchers have developed a self-guided version of trauma intervention, backed by Microsoft Israel R&D engineers.

Based on EMDR (Eye Movement Desensitization and Reprocessing), the technology is designed to prevent PTSD from developing after a traumatic event.

Even battlefield medicine has seen dramatic advances. Magen David Adom has helped IDF become the first military in the world to implement whole blood transfusions in combat zones, achieving a 93% survival rate for massive trauma cases.

New chip-bearing dog tags enable medics to track treatment details from battlefield to hospital bed.

Perhaps most surprising is the rise of unconventional treatments like NexoBrid, which uses pineapple stem enzymes to remove dead tissue from severe burns.

Recently FDA-approved for pediatric use, the U.S. Department of Defense has invested $15 million in this groundbreaking technology for Israel’s wounded soldiers.

The post Inside Israel’s next-gen fight to save its heroes appeared first on World Israel News.

In one of his posts, Tribout described the COVID-19 vaccine as the ‘Jew Jab.’

By JNS

Pascal Tribout, 38, of Quebec, pleaded guilty on Friday to charges related to antisemitic hate speech and using 3D printers to create gun parts.

Following a tip from the Canadian Security Intelligence Service in November 2023, investigators found that Tribout was an active member of the GDL Chat 2.0 channel on Telegram, a cross-platform social media messaging platform.

Police said that Tribout had posted 66 “racist, antisemitic, anti-government, conspiracy and alarmist” messages on the channel, which is known for promoting “antisemitism and white supremacist themes,” between March 14 and April 2, 2024.

In one of his posts, Tribout described the COVID-19 vaccine as the “Jew Jab.”

When law enforcement searched his home, they found a document titled “Every Single Aspect of the COVID Agenda is Jewish,” along with other antisemitic propaganda and a 1947-style German military uniform.

Tribout was also found in possession of 13 3D printers and gun casings for several types of guns, such as FGC-9, AR-15, Tec-22 and Derringer.

The weapons were not functional and thus did not meet the definition of a firearm under Canadian law.

Tribout, who was arrested by the Royal Canadian Mounted Police on June 13, pleaded guilty to four charges, including possession and distribution of firearm-related computer data for use with 3D printers, wilful promotion of hatred and attempting to manufacture prohibited firearms with a 3D printer.

Tribout’s sentencing hearing is scheduled for April 7, 2025.

“We believe that the sentence handed down must be strictly exemplary and send a clear message to both the accused and any potential accomplices,” Henry Topas, B’nai Brith Canada’s director general for Quebec, said in a statement submitted to the court.

“These types of actions and behavior will not be tolerated in our country.”

The post Canadian man pleads guilty to promoting Jew-hate speech, attempting to make 3D-printed guns appeared first on World Israel News.

This technological advance promises to change how viruses are monitored and managed in healthcare settings, providing a rapid, accurate, and portable tool for health professionals.

By Pesach Benson, TPS

Israeli and German researchers unveiled a groundbreaking new method for detecting viruses and nanoparticles that offers faster, more accurate results at a fraction of the cost of traditional techniques.

The method combines advanced microscopy techniques with a 3D-printed setup. Its portable nature means it can be deployed in hospitals, clinics, and even mobile units in remote or underserved areas, making virus detection accessible in places where advanced lab facilities might not be available.

This innovative approach, led by Prof. Dr. Eitan Lerner of the Hebrew University, PhD candidate Mrs. Paz Drori, and colleagues from Ludwig-Maximilians University Munich and the Technical University of Dortmund, combines advanced microscopy techniques with a 3D-printed setup.

Traditionally, virus detection relies heavily on polymerase chain reaction (PCR) methods, which, while highly accurate, can be time-consuming and require specialized lab equipment.

In contrast, antigen-based tests, though quicker, tend to lack the precision and sensitivity needed to reliably detect small quantities of virus.

The new method developed by Lerner’s team addresses these shortcomings by offering a faster, more cost-effective alternative capable of identifying single virus particles with great accuracy.

The team’s approach merges confocal fluorescence microscopy with microfluidic laminar flow, an innovative technique allowing researchers to examine nanoparticles and viruses in real time.

This combination of technologies is further enhanced by a 3D-printed microscopy device, known as Brick-MIC, which offers a portable and affordable solution for virus detection.

Brick-MIC uses laminar flow within a microfluidic channel to direct the movement of viruses or nanoparticles, while fluorescent dyes and labeled antibodies help distinguish specific virus particles with unparalleled sensitivity.

The development of this method also saw collaboration with Prof. Dr. Thorben Cordes’ group from Ludwig-Maximilians University and the Israel Institute for Biological Research (IIBR).

Together, the teams were able to test the technology on both fluorescent beads and real viruses, including those carrying the SARS-CoV-2 Spike protein. These trials demonstrated the system’s high level of accuracy and specificity in detecting clinically relevant virus concentrations.

One of the critical innovations of this method is its hydrodynamic focusing capability, which significantly boosts sensitivity and allows for the detection of viruses at low concentrations—something crucial for clinical and diagnostic applications.

This technological advance promises to change how viruses are monitored and managed in healthcare settings, providing a rapid, accurate, and portable tool for health professionals.

During viral outbreaks or pandemics, the technology could be used for mass screening in airports, schools, or workplaces. It could also be integrated into public health infrastructure for continuous monitoring of viral outbreaks in real time, allowing for faster responses and better containment strategies.

In addition, the ability to detect specific virus strains at a nanoparticle level would allow for more personalized healthcare interventions.

For example, doctors could use this technology to better understand the virus type affecting an individual, allowing for more precise and effective treatments, such as antiviral drugs or vaccines suited to the specific pathogen.

Patients with chronic conditions or weakened immune systems could benefit from regular health monitoring using this rapid detection system, enabling early intervention before infections worsen.

The system could be used to regularly screen for viruses in high-risk environments like hospitals, especially in ICU wards, to prevent hospital-acquired infections.

It would help in quickly identifying viral threats and isolating infected patients to protect vulnerable populations. Routine use of the technology could also ensure that healthcare workers are not unknowingly carrying viruses.

Studies on this new approach to detecting viruses were recently published in the peer-reviewed iScience and Science Advances journals.

The post Game-changing 3D-printed virus detector promises quicker diagnosis and wider access appeared first on World Israel News.